Visuomotor Prosthetic for Paralysis
Launched by RICHARD A. ANDERSEN, PHD · Oct 7, 2013
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way for people with severe paralysis, specifically those with quadriplegia, to communicate and interact with technology. Researchers are testing a device called a "brain-chip" that can pick up brain signals and allow users to control a computer or tablet just by thinking about it. The goal is to help participants use devices to make phone calls, manage finances, watch movies, play games, and even control smart home devices, which could significantly enhance their quality of life.
To be eligible for this trial, participants need to be between 22 and 65 years old, have a medical condition that causes paralysis, and be able to give informed consent. They should also be able to communicate verbally with help if needed and have a stable support system in place. Each participant will have the brain-chip implanted for a period of 53 weeks to over six years, during which they will undergo training to learn how to control the tablet. The trial is currently recruiting participants, and those interested should be prepared to travel to the study location regularly for check-ups and training sessions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pathology resulting in paralysis
- • Age 22-65 years
- • Able to provide informed consent
- • Understand and comply with instructions, if necessary, with the aid of a translator
- • Able to communicate via speech
- • Surgical clearance
- • Life expectancy greater than 12 months
- • Live within 60 miles of study location and willing to travel up to 5 days per week
- • A regular caregiver to monitor the surgical site
- • Psychosocial support system
- • Stable ventilator status
- Exclusion Criteria:
- • Intellectual impairment
- • Psychotic illness or chronic psychiatric disorder, including major depression if untreated
- • Poor visual acuity
- • Pregnancy
- • Active infection or unexplained fever
- • Scalp lesions or skin breakdown
- • HIV or AIDS infection
- • Active cancer or chemotherapy
- • Medically uncontrolled diabetes
- • Autonomic dysreflexia
- • History of seizure
- • Implanted hydrocephalus shunt
- • History of supratentorial brain injury or neurosurgery
- • Medical conditions contraindicating surgery and chronic implantation of a medical device
- • Unable to undergo MRI or anticipated need for MRI during study
- • Nursing an infant or unwilling to bottle-feed infant
- • Chronic oral or intravenous use of steroids or immunosuppressive therapy
- • Suicidal ideation
- • Drug or alcohol dependence
- • Planning to become pregnant, or unwilling to use adequate birth control
- • Implanted Cardiac Defibrillator, Pacemaker, vagal nerve stimulator, or spinal cord stimulator.
About Richard A. Andersen, Phd
Richard A. Andersen, PhD, is a distinguished clinical trial sponsor known for his innovative contributions to neuroscience and rehabilitation research. With a robust academic background and extensive experience in translational science, Dr. Andersen leads initiatives aimed at advancing therapeutic interventions for neurological disorders. His work emphasizes the integration of cutting-edge technology and rigorous methodologies to enhance patient outcomes and drive forward the understanding of brain function. Committed to fostering collaboration across disciplines, Dr. Andersen is dedicated to translating scientific discoveries into practical applications that improve the quality of life for individuals affected by cognitive and motor impairments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Pomona, California, United States
Pasadena, California, United States
Patients applied
Trial Officials
Richard A Andersen, PhD
Principal Investigator
California Institute of Technology
Ausaf Bari, MD, PhD
Principal Investigator
University of California, Los Angeles
Emily Rosario, PhD
Principal Investigator
Casa Colina Hospital and Centers for Healthcare
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials